The Nomination Committee in Surgical Science, which was appointed in accordance with the resolution of the Annual General Meeting of May 6, 2020, comprises:
Åsa Hedin, appointed by Marknadspotential AB
Tommy Forsell, appointed by Landsnora Software AB
Anna Sundberg, appointed by Handelsbanken Fonder
Roland Bengtsson, Chairman of the Board

In preparation for the Annual General Meeting of Surgical Science on Wednesday, May 12, 2021, the Nomination Committee proposes the following:
– that Roland Bengtsson, Chairman of the Board, be the chairman of the Meeting.
– that the Board of Directors shall consist of six Board members, without deputies.
– that a registered auditing company be appointed as auditor.
– that fees to the Board of Directors shall be paid totaling SEK 1,050,000 (369,000), of which SEK 300,000 shall be paid to the Chairman of the Board (123,000) and SEK 150,000 to each of other members (61,500). It is proposed that the auditors’ fees, for the period extending until the end of the next Annual General Meeting, be paid in accordance with approved invoicing.
– that Board members Roland Bengtsson, Jan Bengtsson, Thomas Eklund and Tommy Forsell be re‑elected, and that Henrik Falconer and Elisabeth Hansson be newly elected. Nils Sellbom has declined re-election.
– re-election of Roland Bengtsson as Chairman of the Board.

Details of new Board members proposed for election:
Henrik Falconer
Born 1973. Other assignments: Board member of the Society of European Robotic Gynecological Surgery (SERGS). Background: Chief Physician and Head of the Gynecological Cancer Section, Karolinska University Hospital. Head of Robot Gynecological Surgery since 2013. Education: Medical degree from Karolinska Institutet, Doctoral degree in Obstetrics and Gynecology 2008, Associate Professor in Obstetrics and Gynecology 2015.
Shareholding: 0 shares
Henrik Falconer is independent in relation to both the Company and its management, as well as to major shareholders.

Elisabeth Hansson
Born 1975. Other assignments: Board member of GHP Specialty Care and Mentor International. Business Area Manager Communication Services at Postnord. Background: Management consultant for 17 years, focusing on healthcare in the Nordic region. Partner at Boston Consulting Group and Associate Principal at McKinsey & Company. Education: MBA from the Stockholm School of Economics.
Shareholding: 250 shares
Elisabeth Hansson is independent in relation to the Company and its management, as well as to major shareholders.

“Surgical Science has developed amazingly in recent years and we are now strengthening the Board in two areas of importance for our continued growth. Elisabeth Hansson has solid expertise in management consulting with extensive experience in both Swedish and international healthcare. Henrik Falconer is a highly qualified surgeon with leading-edge expertise in robotic surgery. Simulation in robotic surgery is the area in which we are experiencing our strongest growth and Henrik brings both the practical experience and medical expertise. Elisabeth and Henrik bring additional expertise to Surgical Science to help us in our ambition to consolidate the industry and cement our role in medical VR simulation,” says Roland Bengtsson, Chairman of the Board.

Gothenburg, April 7, 2021
Surgical Science Sweden AB (publ)

The full press release is available in the attachment or via
https://surgicalscience.com/aktien/pressmeddelanden/

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

For further information, please contact:

Gisli Hennermark, CEO
Telephone: +46-70-420 83 00
E-mail: gisli.hennermark@surgicalscience.com

Anna Ahlberg, CFO
Telephone: +46-70-855 38 35
E-mail: anna.ahlberg@surgicalscience.com

About Surgical Science Sweden AB (publ)

One of the biggest challenges within healthcare globally is how injuries during care can be reduced. Medical education and training are key, as a large part of the training today can be performed outside the operating room. Surgical Science is a world leader in the manufacture of virtual reality simulators for evidence-based laparoscopic and endoscopic training. The simulators enable surgeons and other medical specialists to train and improve their psychomotor skills and instrument handling before entering the operating room. In parallel with its own products, Surgical Science works with simulation solutions for medical technology companies that develop surgical instruments for clinical use, such as robotic surgery.

Surgical Science is headquartered in Gothenburg, Sweden and present in Stockholm, Sweden, as well as in Seattle, Washington, in the US. Through sales offices in the US, France, China and UAE as well as a global network of distributors, Surgical Science maintains a presence in most markets around the world. Surgical Science Sweden AB (publ) is traded on Nasdaq First North Growth Market. Certified Adviser is Erik Penser Bank (Telephone: 08-463 83 00; E-mail: certifiedadviser@penser.se).

Attachments

The Nomination Committee’s proposal regarding Board members etc. in Surgical Science Sweden AB (publ)

© Modular Finance, source Nordic Press Releases